Sat.Jul 12, 2025

article thumbnail

CredibleMind to Showcase Insights and Advancements in Population Behavioral Health for Local Communities at NACCHO 360 Conference

Credible Mind

Rethink Mental Health CredibleMind thought leaders will share practical, scalable approaches to improving population mental health nationwide SAUSALITO, Calif.— DATE — CredibleMind, Inc. , a leader in digital population-based mental health solutions, announces its participation at NACCHO 360 , taking place July 14–18, 2025, in Anaheim, California. CredibleMind will be featured prominently across several sessions and panels— all designed to empower attendees with practical, evidence-based strateg

article thumbnail

Double Jointed with ADHD? It’s Not a Coincidence.

ADDitude

On the school playground, did you delight and amaze friends by bending your fingers backward, putting your legs behind your head, or doing splits? These physical abilities are generally rare — but not among people with ADHD, 80% of whom are hypermobile. While research is still emerging, studies show a link between hypermobility and neurodevelopmental disorders, including ADHD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Psychiatry Criticism Politics: When the Enemy of Your Enemy Is Not Your Friend

Mad in America

M any people from very different groups do not like establishment psychiatry. Some of them are my friends, however, some of them belong to authoritarian groups that I dislike as much as I dislike establishment psychiatry. Who are enemies of establishment psychiatry that are not my friends? What kind of dealings—if any—does it make sense to have with them?

article thumbnail

Long-Acting Injectable Antipsychotics in the Treatment of Schizoaffective Disorder: A Retrospective Mirror Image Study for Hospitalizations and Treatment Costs

Asian Journal of Psychiatry

Publication date: Available online 11 July 2025 Source: Asian Journal of Psychiatry Author(s): Bengisu Büşra MAMMADOV, Eren YILDIZHAN, Nesrin Buket TOMRUK

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia

Psychiatric Times

Discover groundbreaking schizophrenia treatment with xanomeline-trospium, targeting cholinergic pathways for improved symptoms and fewer side effects.

52
article thumbnail

The Guy I’m Dating Wants Us to Be Exclusive. Do I Have to Agree?

The New York Times -- Mental Health

Pressure and trust issues made me skeptical of monogamy.

61

More Trending

article thumbnail

Awareness of Multiple Treatment Options for Tardive Dyskinesia: Tips from Dr Jonathan Meyer

Psychiatric Times

Dr. Jonathan Meyer highlights effective VMAT 2 inhibitors for tardive dyskinesia treatment, emphasizing tailored approaches for improved patient outcomes.

69
article thumbnail

Well-Rounded Examination for Treatment of Tardive Dyskinesia

Psychiatric Times

Innovative approaches enhance understanding of tardive dyskinesia's impact on patients' lives, shifting focus from detection to functional well-being.

77
article thumbnail

Clinician Tips in Prescribing New Xanomeline-Trospium for Schizophrenia

Psychiatric Times

Clinicians explore the potential of xenomeline-trospium for schizophrenia, emphasizing cautious evaluation and management of side effects for optimal patient outcomes.

52
article thumbnail

Addressing Agitation in Dementia: Emerging Options and Clinical Considerations

Psychiatric Times

News Media Peer Exchange Case-Based Psych Perspectives Clinical Case Collective Insights Peers & Perspectives Slideshows Videos Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Between the Lines Expert Perspectives Clinical Consult Clinical Scales Interactive Tools Partner Perspectives Q&A Quizzes Series Special Reports Sponsored Subscribe Spotlight Long-Acting Injectable Therapy in the Management of Adult Pati